Outset Medical stock more than doubles in Nasdaq debut
September 16, 2020
Stock in Outset Medical surged nearly 125% in its public debut Tuesday, closing the day at $60.68 per share after the company offered almost 9 million shares at $27 apiece. The San Jose-based developer of kidney dialysis technology had previously marketed 7.6 million shares at a range of $22 to $24 apiece. Outset Medical was valued at $725 million in February, according to PitchBook data.